Mia's Feed
Medical News & Research

Innovative Immunology-Based Radiation Therapy Techniques Highlighted at International Conference

Innovative Immunology-Based Radiation Therapy Techniques Highlighted at International Conference

Share this article

Researchers at the University of Kentucky highlight innovative immunology-driven radiation therapy techniques that enhance cancer treatment while preserving immune function, showcased at a major international conference.

2 min read

At a recent prominent international conference, researchers from the University of Kentucky Markey Cancer Center introduced groundbreaking advancements in radiation therapy that emphasize immunology-focused approaches. Dr. Weisi Yan, an associate professor in the Department of Radiation Medicine, presented three detailed studies showcasing methods to enhance cancer treatment efficacy while safeguarding patients' immune systems. The key challenge addressed by this research is balancing effective tumor eradication with preservation of the body's natural defenses, as traditional radiation therapy often compromises immune function.

Dr. Yan emphasized that the future of radiotherapy lies in not only targeting and destroying tumors locally but also in activating the body's systemic immune response to fight cancer more effectively. His research explores innovative techniques such as artificial intelligence-guided radiation targeting, advanced modalities like FLASH radiotherapy, and stereotactic body radiation therapy, which are designed to stimulate immune responses against cancer cells throughout the body.

Particularly promising are two experimental treatments developed by Yan called SCART and SBRT-PATHY. These methods focus on damaging the tumor core while conserving immune-rich tissue around the tumor margins, showing early signs of reducing side effects and improving outcomes.

Implementation of these approaches at the UK Markey Cancer Center has already demonstrated tangible benefits. For instance, by carefully safeguarding critical structures in lung cancer patients during radiation, Yan observed a 20-30% increase in lymphocyte counts, which are vital white blood cells that combat infections and cancer. This indicates a significant enhancement in immune system resilience compared to conventional treatments.

The advancements presented underscore a transformative shift in radiation oncology, aiming to not only control tumors locally but also mobilize and strengthen the immune system to attack cancer globally. These innovations hold promise for improving patient survival rates and quality of life in the future.

For more insights, visit the conference website: International Conference on Advances in Radiation Oncology. Source: University of Kentucky.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Advanced AI Analysis Uncovers Hidden Health Risks in Inflammatory Bowel Disease Patients

A new AI-powered analysis reveals that over half of inflammatory bowel disease patients experience additional autoimmune, mental health, or systemic conditions, emphasizing the need for holistic, multidisciplinary care.

Brain's Central Switchboard: Neurons Function as Precise Movement 'Brakes'

New research uncovers how neurons in the brain's basal ganglia act as precise control switches, enabling fine-tuned movement regulation. This breakthrough enhances understanding of motor control and offers insights for treating disorders like Parkinson's disease.

Innovative PET Technique Enables Monitoring of Engineered T Cells in Immunotherapy

A groundbreaking PET imaging method developed at TUM enables real-time tracking of engineered T cells during immunotherapy, promising safer and more effective treatments. Source: https://medicalxpress.com/news/2025-06-pet-based-technique-cells-immunotherapy.html

Innovative Drug Therapy Demonstrates Promise in Laboratory Neuron Models of Epilepsy

Researchers have demonstrated that targeted drug treatments can improve neural function in laboratory models of epilepsy, paving the way for personalized therapies and advanced neurological research.